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old obese rats). Endothelial NO-synthase (eNOS) blockade 
(L-NAME) was reduced in old obese rats although eNOS expression 
level was unaffected. However, indomethacin improved AMR in 
old obese rats only, suggesting that vasoconstrictor prostanoids 
were involved. Similarly, COX2 inhibition (NS398) and TxA2/PGH2 
receptor blockade (SQ29548) increased AMR in arteries from old 
obese rats only. Old obese rats presented the highest levels of 
blood TxB2 (TxA2 metabolite) associated with an increased COX2 
immunostaining and expression level. Chronic inhibition of COX2 
with NS398 (3 weeks) restored AMR in old obese rats (78 % versus 
57 % in control obese rats) to the level observed in solventtreated 
old lean rats (84 %). Taken together, these data show that obesity 
in old rats is associated with a reduced endothelium-mediated 
relaxation due to an excessive production of COX-2 derivatives, 
most probably TxA2.
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Objective — To study the role of the serotoninergic 5-HT2B 
receptor in the development of cardiac hypertrophy and its link 
with left ventricular superoxide anion generation in a mouse model 
of angiotensin II-induced hypertension.
Methods — Wild-type and 5-HT2B receptor knock-out (KO) mice 
were perfused with angiotensin II (0.2 mg.kg-1.d-1) for 14 days 
with or without SB215505 (1mg.kg-1.d-1), an antagonist of the 
5-HT2B receptor. Heart rate and blood pressure were measured 
by tail-cuff plethysmography. Cardiac hypertrophy was evaluated 
by echocardiography and direct measurement of heart weight. 
Superoxide anion production and maximal NAD(P)H oxidase activity 
were measured by a chemiluminescence method using lucigenin. 
Superoxide anion production was also measured in primary left 
ventricular  broblasts cell cultures.
Results — Angiotensin II increased superoxide anion production 
(+32 %), the maximal activity of NAD(P)H oxidase (+84 %) in left 
ventricle of wild-type mice concomitantly with the arterial blood 
pressure (+37mmHg) and the heart/body weight ratio (+17 %). A 
pharmacological blockade (SB215505) or a genetic suppression of 
the 5-HT2B receptor prevented the increased superoxide anion 
production and cardiac hypertrophy but had no effect on cardiac 
hemodynamics or blood pressure. Angiotensin II also increased 
NAD(P)H oxidase activity in cultured cardiac  broblasts and this 
increase was prevented by SB215505.
Conclusion — The 5-HT2B receptor is a new potential target for the 
prevention of cardiac hypertrophy and its associated superoxide 
anion production. Cells of the extracellular matrix could possibly 
be involved in this mechanism.
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Nitric oxide (NO) production by endothelial NO-synthase (eNOS) is 
critically dependent on the cofactor, tetrahydrobiopterin (BH4). 
Depletion in BH4 consecutive to an increase of reactive oxygen 
species (ROS) production by NADPH-oxidases and/or eNOS over-
expression, favour eNOS uncoupling. This study investigates the 
potential role of NADPH-oxidases and uncoupled eNOS in pulmonary 
arterial hypertension induced by chronic hypoxia.
Male C57BL/6 and eNOS knockout (eNOS-/-) mice were exposed 
or not to hypobaric hypoxia (0.5 atm) for 21 days. Fulton index 
(right ventricular / left ventricular + septum weight ratio) was 
determined. Lungs were used for measurement of BH4 (by HPLC), 
for expression of eNOS (by western-blotting) and of the NADPH-
oxidases subunits Nox1, Nox2 and Nox4 (by RT-PCR). Pulmonary 
arteries were also mounted in a wire myograph for evaluation of 
vasomotor responses.
Chronic hypoxia induced a marked up-regulation of Nox1, Nox2 and 
Nox4 mRNAs in lungs, and an increase of ROS levels in pulmonary 
arteries. BH4 levels, as well as eNOS expression, were enhanced 
in lungs from hypoxic WT mice (1.25 and 4 fold increase compared 
to normoxic WT mice, respectively). In pulmonary arteries from 
hypoxic WT mice, the contractile response to phenylephrine was 
about 1.8 greater than in those from normoxic WT mice. The 
use of ROS scavengers (PEG-SOD or catalase) and NOS inhibitor 
(L-NAME) revealed the involvement of ROS in hypoxia-induced 
hyper-reactivity to phenylephrine, and a loss of NO-dependent 
relaxation. Chronic treatment of hypoxic WT mice with the BH4 
precursor sepiapterin preserved the vasorelaxant effect of NO. This 
treatment and the deletion of eNOS gene abolished the inhibitory 
effect of catalase on phenylephrine-induced contraction, and also 
attenuated hypoxia-induced right ventricular hypertrophy.
These data show that chronic hypoxia induced an up-regulation of 
Nox isoforms and eNOS in lungs. They suggest that uncoupled eNOS 
participates to right ventricular hypertrophy and to alterations 
of vasomotor responses in pulmonary arteries in hypoxia-induced 
pulmonary hypertension. The weak increase in BH4 and the large 
over-expression of eNOS suggest the existence of compensatory 
mechanisms on BH4 synthesis, which may moderate eNOS 
dysfunction.
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